Osteoprotegerin ligand: a regulator of immune responses and bone physiology
被引:130
作者:
Kong, YY
论文数: 0引用数: 0
h-index: 0
机构:
Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South KoreaPohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea
Kong, YY
[1
]
Boyle, WJ
论文数: 0引用数: 0
h-index: 0
机构:Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea
Boyle, WJ
Penninger, JM
论文数: 0引用数: 0
h-index: 0
机构:Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea
Penninger, JM
机构:
[1] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea
[2] Amgen Inc, Dept Cell Biol, Thousand Oaks, CA 91320 USA
[3] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[4] Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada
来源:
IMMUNOLOGY TODAY
|
2000年
/
21卷
/
10期
关键词:
D O I:
10.1016/S0167-5699(00)01718-7
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
The TNF-family molecule osteoprotegerin ligand (OPGL, also known as TRANCE, RANKL and ODF) is a key regulator of bone remodeling and essential for the development and activation of osteoclasts. Intriguingly, OPGL also regulates T cell-dendritic cell communications, dendritic cell survival and lymph-node organogenesis. Here, Young-Yun Kong and colleagues discuss the role of OPGL, and its receptor RANK, in the immune system and in bone metabolism.